Memantine in Patients With Chronic Glaucoma

Allergan

Status and phase: Completed; Phase 3

Conditions: Open-Angle Glaucoma

Treatments: Drug: memantine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00168350

192944-005

Details and patient eligibility

About

Randomized double-masked clinical trial of memantine in patients with glaucoma

Enrollment: 1,179 patients

Sex: All

Ages: 18 to 82 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• glaucoma damage on examination of visual field and optic disc
• good visual acuity (with glasses if needed)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind